vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and CS Disco, Inc. (LAW). Click either name above to swap in a different company.
CS Disco, Inc. is the larger business by last-quarter revenue ($41.9M vs $34.1M, roughly 1.2× Karyopharm Therapeutics Inc.). CS Disco, Inc. runs the higher net margin — -23.0% vs -299.9%, a 276.9% gap on every dollar of revenue. On growth, CS Disco, Inc. posted the faster year-over-year revenue change (14.3% vs 11.6%). Over the past eight quarters, CS Disco, Inc.'s revenue compounded faster (7.9% CAGR vs 1.4%).
CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.
KPTI vs LAW — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $41.9M |
| Net Profit | $-102.2M | $-9.6M |
| Gross Margin | — | 74.2% |
| Operating Margin | -52.4% | 1.7% |
| Net Margin | -299.9% | -23.0% |
| Revenue YoY | 11.6% | 14.3% |
| Net Profit YoY | -232.0% | 15.6% |
| EPS (diluted) | $-7.02 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $41.9M | ||
| Q4 25 | $34.1M | $41.2M | ||
| Q3 25 | $44.0M | $40.9M | ||
| Q2 25 | $37.9M | $38.1M | ||
| Q1 25 | $30.0M | $36.7M | ||
| Q4 24 | $30.5M | $37.0M | ||
| Q3 24 | $38.8M | $36.3M | ||
| Q2 24 | $42.8M | $36.0M |
| Q1 26 | — | $-9.6M | ||
| Q4 25 | $-102.2M | $-8.5M | ||
| Q3 25 | $-33.1M | $-13.7M | ||
| Q2 25 | $-37.3M | $-10.8M | ||
| Q1 25 | $-23.5M | $-11.4M | ||
| Q4 24 | $-30.8M | $-25.2M | ||
| Q3 24 | $-32.1M | $-9.2M | ||
| Q2 24 | $23.8M | $-10.8M |
| Q1 26 | — | 74.2% | ||
| Q4 25 | — | 75.1% | ||
| Q3 25 | — | 75.5% | ||
| Q2 25 | — | 74.6% | ||
| Q1 25 | — | 74.1% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 73.1% | ||
| Q2 24 | — | 74.2% |
| Q1 26 | — | 1.7% | ||
| Q4 25 | -52.4% | -22.4% | ||
| Q3 25 | -34.6% | -35.3% | ||
| Q2 25 | -64.3% | -31.0% | ||
| Q1 25 | -110.8% | -34.4% | ||
| Q4 24 | -102.4% | -70.6% | ||
| Q3 24 | -67.8% | -30.0% | ||
| Q2 24 | -65.7% | -34.4% |
| Q1 26 | — | -23.0% | ||
| Q4 25 | -299.9% | -20.7% | ||
| Q3 25 | -75.2% | -33.4% | ||
| Q2 25 | -98.2% | -28.4% | ||
| Q1 25 | -78.2% | -31.1% | ||
| Q4 24 | -100.8% | -68.1% | ||
| Q3 24 | -82.7% | -25.3% | ||
| Q2 24 | 55.6% | -30.1% |
| Q1 26 | — | $-0.15 | ||
| Q4 25 | $-7.02 | $-0.13 | ||
| Q3 25 | $-3.82 | $-0.22 | ||
| Q2 25 | $-4.32 | $-0.18 | ||
| Q1 25 | $-2.77 | $-0.19 | ||
| Q4 24 | $-2.33 | $-0.43 | ||
| Q3 24 | $-3.85 | $-0.15 | ||
| Q2 24 | $-2.97 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $103.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $123.9M |
| Total Assets | $108.4M | $162.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $103.0M | ||
| Q4 25 | $60.5M | $114.6M | ||
| Q3 25 | $37.7M | $113.5M | ||
| Q2 25 | $38.7M | $114.5M | ||
| Q1 25 | $38.8M | $118.8M | ||
| Q4 24 | $62.5M | $129.1M | ||
| Q3 24 | $72.8M | $126.8M | ||
| Q2 24 | $84.8M | $130.0M |
| Q1 26 | — | $123.9M | ||
| Q4 25 | $-292.9M | $128.1M | ||
| Q3 25 | $-269.3M | $130.6M | ||
| Q2 25 | $-238.9M | $137.9M | ||
| Q1 25 | $-205.9M | $142.2M | ||
| Q4 24 | $-186.0M | $147.5M | ||
| Q3 24 | $-159.6M | $167.3M | ||
| Q2 24 | $-132.1M | $170.9M |
| Q1 26 | — | $162.4M | ||
| Q4 25 | $108.4M | $173.6M | ||
| Q3 25 | $96.2M | $174.8M | ||
| Q2 25 | $104.9M | $164.9M | ||
| Q1 25 | $127.7M | $168.0M | ||
| Q4 24 | $164.4M | $180.3M | ||
| Q3 24 | $189.5M | $194.4M | ||
| Q2 24 | $214.0M | $198.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $-11.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-11.7M | ||
| Q4 25 | $-11.8M | $762.0K | ||
| Q3 25 | $-5.9M | $-979.0K | ||
| Q2 25 | $-18.7M | $-4.2M | ||
| Q1 25 | $-39.0M | $-10.5M | ||
| Q4 24 | $-25.8M | $2.1M | ||
| Q3 24 | $-19.5M | $-2.9M | ||
| Q2 24 | $-38.5M | $-650.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | $255.0K | ||
| Q3 25 | — | $-2.0M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | — | $-11.0M | ||
| Q4 24 | $-25.9M | $1.5M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | -5.0% | ||
| Q2 25 | — | -13.6% | ||
| Q1 25 | — | -30.1% | ||
| Q4 24 | -84.7% | 4.1% | ||
| Q3 24 | — | -10.3% | ||
| Q2 24 | — | -3.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 1.2% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 1.4% | ||
| Q4 24 | 0.2% | 1.5% | ||
| Q3 24 | 0.0% | 2.4% | ||
| Q2 24 | 0.0% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.62× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
LAW
Segment breakdown not available.
